X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Bajaj Finance with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAJAJ FINANCE vs INDOCO REMEDIES - Comparison Results

BAJAJ FINANCE    Change

Established in 1987, Bajaj Finance Ltd is a subsidiary of Bajaj Finserv Ltd, the financial services arm of the Bajaj Group. In the early days, Bajaj Finance provided loans for two and three-wheelers manufactured by Bajaj Auto Ltd. Over the years, the... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAJAJ FINANCE INDOCO REMEDIES BAJAJ FINANCE/
INDOCO REMEDIES
 
P/E (TTM) x 52.0 282.8 18.4% View Chart
P/BV x 11.1 2.5 440.8% View Chart
Dividend Yield % 0.1 0.5 21.6%  

Financials

 BAJAJ FINANCE   INDOCO REMEDIES
EQUITY SHARE DATA
    BAJAJ FINANCE
Mar-18
INDOCO REMEDIES
Mar-18
BAJAJ FINANCE/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,989317 626.7%   
Low Rs1,153178 647.2%   
Sales per share (Unadj.) Rs1,168.6113.1 1,033.5%  
Earnings per share (Unadj.) Rs232.54.5 5,204.6%  
Cash flow per share (Unadj.) Rs241.311.8 2,042.8%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.30.4 63.1%  
Book value per share (Unadj.) Rs1,438.473.2 1,963.7%  
Shares outstanding (eoy) m115.0392.15 124.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.2 61.3%   
Avg P/E ratio x6.855.5 12.2%  
P/CF ratio (eoy) x6.521.0 31.0%  
Price / Book Value ratio x1.13.4 32.3%  
Dividend payout %1.722.4 7.7%   
Avg Mkt Cap Rs m180,68922,830 791.4%   
No. of employees `00015.35.5 279.9%   
Total wages/salary Rs m14,1962,209 642.6%   
Avg. sales/employee Rs Th8,805.21,910.1 461.0%   
Avg. wages/employee Rs Th929.9405.0 229.6%   
Avg. net profit/employee Rs Th1,751.775.5 2,321.5%   
INCOME DATA
Net Sales Rs m134,42010,419 1,290.1%  
Other income Rs m23947 509.0%   
Total revenues Rs m134,65910,466 1,286.6%   
Gross profit Rs m88,0871,349 6,528.4%  
Depreciation Rs m1,021677 150.7%   
Interest Rs m46,343235 19,712.2%   
Profit before tax Rs m40,962484 8,463.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14,22172 19,642.1%   
Profit after tax Rs m26,741412 6,496.9%  
Gross profit margin %65.512.9 506.0%  
Effective tax rate %34.715.0 232.1%   
Net profit margin %19.94.0 503.6%  
BALANCE SHEET DATA
Current assets Rs m377,8065,373 7,031.7%   
Current liabilities Rs m227,4584,157 5,471.8%   
Net working cap to sales %111.811.7 958.4%  
Current ratio x1.71.3 128.5%  
Inventory Days Days068 0.0%  
Debtors Days Days93273 1,280.5%  
Net fixed assets Rs m4,6706,244 74.8%   
Share capital Rs m1,150184 624.1%   
"Free" reserves Rs m164,3066,566 2,502.6%   
Net worth Rs m165,4576,750 2,451.3%   
Long term debt Rs m458,9631,233 37,229.3%   
Total assets Rs m868,24312,363 7,023.1%  
Interest coverage x1.93.1 61.6%   
Debt to equity ratio x2.80.2 1,518.8%  
Sales to assets ratio x0.20.8 18.4%   
Return on assets %8.45.2 160.9%  
Return on equity %16.26.1 265.0%  
Return on capital %14.09.0 155.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m3151,143 27.6%   
Net fx Rs m-3152,619 -12.0%   
CASH FLOW
From Operations Rs m-204,6141,227 -16,673.2%  
From Investments Rs m9,712-1,360 -714.0%  
From Financial Activity Rs m195,033-388 -50,305.1%  
Net Cashflow Rs m131-521 -25.1%  

Share Holding

Indian Promoters % 61.6 59.2 104.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.1 12.5 56.8%  
FIIs % 12.2 6.0 203.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.1 22.4 85.3%  
Shareholders   19,952 12,805 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAJAJ FINANCE With:   WONDERLA HOLIDAYS  REDINGTON  NALWA SONS INV  KITEX GARMENTS  JSW HOLDINGS  



Today's Market

Indian Indices Hit Record High as Exit Polls Predict NDA Win; Sensex Ends 1,421 Points Higher(Closing)

Indian share markets witnessed huge buying interest today. The benchmark indices opened gap-up after Exit Polls for the Lok Sabha Elections 2019.

Related Views on News

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

BAJAJ FINANCE Announces Quarterly Results (3QFY19); Net Profit Up 38.2% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, BAJAJ FINANCE has posted a net profit of Rs 11 bn (up 38.2% YoY). Sales on the other hand came in at Rs 50 bn (up 40.5% YoY). Read on for a complete analysis of BAJAJ FINANCE's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

A 10-Bagger in Just 6 Years! The Rebirth of India Will Create More Big Winners Like This(The 5 Minute Wrapup)

May 7, 2019

How a niche tech startup battled all odds to eventually become a 10 bagger.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BAJAJ FINANCE SHARE PRICE


May 20, 2019 03:37 PM

TRACK BAJAJ FINANCE

  • Track your investment in BAJAJ FINANCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BAJAJ FINANCE 5-YR ANALYSIS

COMPARE BAJAJ FINANCE WITH

MARKET STATS